The hypothesis that describes the higher p53 level in the serum of HBV-related cirrhotic patients might be the higher expression of HBx in cirrhotic patients as a consequence of viral replication or integration of viral genome in host genome during the end stage of liver disease, and also an increase of p53 protein half-life in its interaction with HBx. This evidence concerns the gene TP53 and liver disorder.